Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000727094 | SCV000705607 | uncertain significance | not provided | 2017-01-19 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000727094 | SCV000730895 | likely benign | not provided | 2020-10-15 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 31983221) |
Revvity Omics, |
RCV000727094 | SCV003824215 | uncertain significance | not provided | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003488718 | SCV004241414 | uncertain significance | not specified | 2023-12-13 | criteria provided, single submitter | clinical testing | Variant summary: TTN c.89179G>A (p.Val29727Met) results in a conservative amino acid change located in the A-band domain of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 6.6e-05 in 243132 control chromosomes. c.89179G>A has been reported in the literature in at least one individual affected with Dilated cardiomyopathy (e.g. Mazzarotto_2020). These report(s) do not provide unequivocal conclusions about association of the variant with Limb-Girdle Muscular Dystrophy, Type 2J. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication has been ascertained in the context of this evaluation (PMID: 31983221). Three submitters have cited clinical-significance assessments for this variant to ClinVar after 2014, classifying the variant as uncertain significance (n=2) or likely benign (n=1). Based on the evidence outlined above, the variant was classified as uncertain significance. |